Literature DB >> 22570859

Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury.

Fang Hua1, Jenny I Reiss, Huiling Tang, Jun Wang, Xavier Fowler, Iqbal Sayeed, Donald G Stein.   

Abstract

Progesterone (PROG) has been shown to protect the brain from traumatic injury and is now in Phase III clinical trials. Our work shows that PROG's beneficial effects can be reduced in vitamin D hormone (VDH)-deficient subjects. VDH can modulate neuronal apoptosis, trophic factors, inflammation, oxidative stress, excitotoxicity, and myelin and axon repair. We investigated whether VDH combined with PROG could improve behavioral outcomes more than PROG alone in VDH-sufficient rats given bilateral contusions of the medial frontal cortex. PROG and different doses of VDH (1 μg/kg, VDH1; 2.5 μg/kg, VDH2; 5 μg/kg, VDH3) were injected intraperitoneally 1 h post-injury. Eight additional doses of PROG were given subcutaneously over 8 days with tapering over the last 2 days. Neurobehavioral tests, necrotic cavity, neuronal death and activation of astrocytes were evaluated 21 days post-injury. We found that PROG and PROG + VDH preserve spatial memory processing. VDH1 + PROG improved performance in acquisition more effectively than PROG alone, indicating that the low VDH dose is optimal for combination therapy. There were no significant differences in necrotic cavity size among the groups. The density of positive staining for reactive astrocytes (glial fibrillary acidic protein (GFAP)) increased and the cell bodies and processes of GFAP-positive cells were enlarged in the PROG + VDH1 group. Our data indicate that the combination of PROG and VDH is more effective than PROG alone in preserving spatial and reference memory, and that PROG plus low-dose VDH can activateGFAP reactions up to 21 days after injury. This effect may be one of the mechanisms underlying PROG's neuroprotective effects in combination with VDH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22570859      PMCID: PMC3517217          DOI: 10.1016/j.yhbeh.2012.02.017

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  52 in total

1.  Tapered progesterone withdrawal promotes long-term recovery following brain trauma.

Authors:  Sarah M Cutler; Jacob W Vanlandingham; Donald G Stein
Journal:  Exp Neurol       Date:  2006-06-22       Impact factor: 5.330

2.  Effects of intra-accumbens NMDA and AMPA receptor antagonists on short-term spatial learning in the Morris water maze task.

Authors:  Valentina Ferretti; Francesca Sargolini; Alberto Oliverio; Andrea Mele; Pascal Roullet
Journal:  Behav Brain Res       Date:  2007-01-13       Impact factor: 3.332

Review 3.  Pharmacokinetics of vitamin D toxicity.

Authors:  Glenville Jones
Journal:  Am J Clin Nutr       Date:  2008-08       Impact factor: 7.045

Review 4.  Vitamin D and genomic stability.

Authors:  M Chatterjee
Journal:  Mutat Res       Date:  2001-04-18       Impact factor: 2.433

5.  The septohippocampal cholinergic system and spatial working memory in the Morris water maze.

Authors:  Helena Frielingsdorf; Leon J Thal; Donald P Pizzo
Journal:  Behav Brain Res       Date:  2005-12-05       Impact factor: 3.332

Review 6.  Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies.

Authors:  Alan S Hazell
Journal:  Neurochem Int       Date:  2007-05-10       Impact factor: 3.921

7.  Effects of progesterone on the inflammatory response to brain injury in the rat.

Authors:  Kimberly J Grossman; Cynthia W Goss; Donald G Stein
Journal:  Brain Res       Date:  2004-05-15       Impact factor: 3.252

8.  Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences.

Authors:  Ayuka Ehara; Shuichi Ueda
Journal:  Acta Histochem Cytochem       Date:  2009-12-22       Impact factor: 1.938

Review 9.  Exogenous progesterone: a potential therapeutic candidate in CNS injury and neurodegeneration.

Authors:  Zhiying Hu; Yan Li; Marong Fang; Maria S M Wai; David T Yew
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo.

Authors:  I Ciriza; I Azcoitia; L M Garcia-Segura
Journal:  J Neuroendocrinol       Date:  2004-01       Impact factor: 3.627

View more
  19 in total

Review 1.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

2.  Combination Therapies for Traumatic Brain Injury: Retrospective Considerations.

Authors:  Susan Margulies; Gail Anderson; Fahim Atif; Jerome Badaut; Robert Clark; Philip Empey; Maria Guseva; Michael Hoane; Jimmy Huh; Jim Pauly; Ramesh Raghupathi; Stephen Scheff; Donald Stein; Huiling Tang; Mona Hicks
Journal:  J Neurotrauma       Date:  2015-08-06       Impact factor: 5.269

Review 3.  Progesterone for neuroprotection in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Emin Fidan; Rachel M Stanley; Corina Noje; Hülya Bayir
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

4.  Progesterone and vitamin D combination therapy modulates inflammatory response after traumatic brain injury.

Authors:  Huiling Tang; Fang Hua; Jun Wang; Seema Yousuf; Fahim Atif; Iqbal Sayeed; Donald G Stein
Journal:  Brain Inj       Date:  2015-06-17       Impact factor: 2.311

Review 5.  Sex-related responses after traumatic brain injury: Considerations for preclinical modeling.

Authors:  Claudia B Späni; David J Braun; Linda J Van Eldik
Journal:  Front Neuroendocrinol       Date:  2018-05-18       Impact factor: 8.606

6.  The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Authors:  Marie-France Nissou; Jacques Brocard; Michèle El Atifi; Audrey Guttin; Annie Andrieux; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

7.  Levels of 25-hydroxyvitamin D3, biochemical parameters and symptoms of depression and anxiety in healthy individuals.

Authors:  Gleicilaine A S Casseb; Gabriela Ambrósio; Ana Lúcia S Rodrigues; Manuella P Kaster
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

Review 8.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

9.  Progesterone and vitamin D: Improvement after traumatic brain injury in middle-aged rats.

Authors:  Huiling Tang; Fang Hua; Jun Wang; Iqbal Sayeed; Xiaojing Wang; Zhengjia Chen; Seema Yousuf; Fahim Atif; Donald G Stein
Journal:  Horm Behav       Date:  2013-07-27       Impact factor: 3.587

Review 10.  Effects of Female Sex Steroids Administration on Pathophysiologic Mechanisms in Traumatic Brain Injury.

Authors:  Mohammad Khaksari; Zahra Soltani; Nader Shahrokhi
Journal:  Transl Stroke Res       Date:  2017-11-19       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.